China Sunsine Chemical Holdings

Broker's Calls

CGS International positive on China Sunsine’s undemanding valuation

CGS International unchanged on China Sunsine, keeps 'buy' and target price

Broker's Calls

UOBKH lowers China Sunsine Chemical’s TP to 46 cents with lowered earnings expectations

The analysts have lowered their gross margin assumptions, which led to lower earnings expectations as well.
UOBKH maintains 'buy' on China Sunsine with higher TP of 57.5 cents on improved outlook - THE EDGE SINGAPORE

Broker's Calls

UOBKH maintains 'buy' on China Sunsine with higher TP of 57.5 cents on improved outlook

The company's expansion projects are expected to be completed by end-2023 and are likely to lift sales volume when operational.

Broker's Calls

CGS-CIMB lowers China Sunsine's TP to 60 cents due to potentially weaker FY2023

As at 12.09pm, shares in China Sunsine are trading flat at 41 cents.

Results

China Sunsine to report 'material increase' in net profit for 1HFY2022

China Sunsine will release its results on Aug 11.
A stronger 4Q expected for China Sunsine: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

A stronger 4Q expected for China Sunsine: CGS-CIMB

CGS-CIMB Research expects a shining outlook for China Sunsine.
CGS-CIMB ups China Sunsine's TP on 'strong start to 2021' - THE EDGE SINGAPORE

Broker's Calls

CGS-CIMB ups China Sunsine's TP on 'strong start to 2021'

The analysts have also raised their net profit forecast for FY2021 by 67% to RMB365 million.
China Sunsine Chemical Holdings sees 'overall improvement' in 1Q21; expects 'relatively weaker demand' in months ahead - THE EDGE SINGAPORE

Results

China Sunsine Chemical Holdings sees 'overall improvement' in 1Q21; expects 'relatively weaker demand' in months ahead

The group recorded sales revenue of RMB840 million ($171.7 million), 66% higher y-o-y.
'Add' China Sunsine on ASP uptrend: CGS-CIMB - THE EDGE SINGAPORE

Broker's Calls

'Add' China Sunsine on ASP uptrend: CGS-CIMB

The brokerage raised its TP from 55 to 61 cents due to further upside in ASP in the coming months.
×